NO174326C - Anvendelse av målsökende merket polypeptid - Google Patents

Anvendelse av målsökende merket polypeptid

Info

Publication number
NO174326C
NO174326C NO864203A NO864203A NO174326C NO 174326 C NO174326 C NO 174326C NO 864203 A NO864203 A NO 864203A NO 864203 A NO864203 A NO 864203A NO 174326 C NO174326 C NO 174326C
Authority
NO
Norway
Prior art keywords
targeting
labeled polypeptide
lymphocytes
receptors
activated
Prior art date
Application number
NO864203A
Other languages
English (en)
Norwegian (no)
Other versions
NO864203L (no
NO864203D0 (no
NO174326B (no
Inventor
Thorfinn Ege
Original Assignee
Nycomed Imaging As
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As, Nycomed As filed Critical Nycomed Imaging As
Publication of NO864203D0 publication Critical patent/NO864203D0/no
Publication of NO864203L publication Critical patent/NO864203L/no
Publication of NO174326B publication Critical patent/NO174326B/no
Publication of NO174326C publication Critical patent/NO174326C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO864203A 1985-10-22 1986-10-21 Anvendelse av målsökende merket polypeptid NO174326C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858525974A GB8525974D0 (en) 1985-10-22 1985-10-22 Chemical substance

Publications (4)

Publication Number Publication Date
NO864203D0 NO864203D0 (no) 1986-10-21
NO864203L NO864203L (no) 1987-04-23
NO174326B NO174326B (no) 1994-01-10
NO174326C true NO174326C (no) 1994-04-20

Family

ID=10587035

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864203A NO174326C (no) 1985-10-22 1986-10-21 Anvendelse av målsökende merket polypeptid

Country Status (8)

Country Link
US (1) US4832940A (de)
EP (1) EP0236619B1 (de)
JP (1) JP2727074B2 (de)
AT (1) ATE71306T1 (de)
DE (1) DE3683368D1 (de)
ES (1) ES2040210T3 (de)
GB (1) GB8525974D0 (de)
NO (1) NO174326C (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330896A (en) * 1983-02-24 1994-07-19 Billing Ronald J Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US5342607A (en) * 1986-07-03 1994-08-30 Advanced Magnetics, Inc. Receptor mediated endocytosis type magnetic resonance imaging contrast agents
US5679323A (en) * 1986-07-03 1997-10-21 Advanced Magnetics, Inc. Hepatocyte-specific receptor-mediated endocytosis-type compositions
US5352432A (en) * 1986-07-03 1994-10-04 Advanced Magnetics, Inc. Hepatocyte specific composition and their use as diagnostic imaging agents
US6461825B1 (en) * 1987-09-30 2002-10-08 Sanofi (Societe Anonyme) Immunometric assay kit and method applicable to whole cells
EP0381742B1 (de) * 1988-08-04 1996-06-19 Advanced Magnetics Incorporated Von einem rezeptor induziertes kontrastmittel für den endocytose-typ mri
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
EP0485664A1 (de) * 1990-11-13 1992-05-20 Mallinckrodt Diagnostica (Holland) B.V. Verfahren zur Herstellung von einem diagnostischen Mittel zur Feststellung von Entzündungen
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5605671A (en) * 1992-10-05 1997-02-25 The Regents Of The University Of Michigan Radiolabeled neutrophil activating peptides for imaging
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof
AU5537994A (en) * 1992-10-22 1994-05-09 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
US6008319A (en) * 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
DK1286704T3 (da) 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
ITRM20030159A1 (it) * 2003-04-07 2004-10-08 Uni Degli Studi Di Roma L A Sapienza Citochine radiomarcate e loro usi come traccianti scintigrafici per la visualizzazione delle infiammazioni croniche linfocito-mediate.
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
JP2009539501A (ja) * 2006-06-06 2009-11-19 ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー ヨウ化ポリマー
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
IT201900011013A1 (it) 2019-07-05 2021-01-05 Sapienza Univ Di Roma Composto e composizione radiofarmaceutici per l’imaging con tecnica di Tomografia a Emissione di Positroni (PET) di cellule positive al recettore dell’interleuchina-2, processo per la loro preparazione, relativo kit e loro usi.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472371A (en) * 1979-10-29 1984-09-18 Summa Medical Corporation Radiolabeled antibody to anti-tumor associated antigen and process
AU556548B2 (en) * 1980-03-03 1986-11-06 Milton David Goldenberg Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor-associated markers
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0111344A2 (de) * 1982-12-13 1984-06-20 Sloan-Kettering Institute For Cancer Research Monoklonale Anti-Interleukin-2-Antikörper
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
DE3484198D1 (de) * 1983-07-29 1991-04-04 Milton David Goldenberg Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren.
US4634586A (en) * 1984-05-21 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Reagent and method for radioimaging leukocytes
US4578335A (en) * 1984-05-21 1986-03-25 Immunex Corporation Interleukin 2 receptor
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes

Also Published As

Publication number Publication date
ATE71306T1 (de) 1992-01-15
US4832940A (en) 1989-05-23
DE3683368D1 (de) 1992-02-20
EP0236619B1 (de) 1992-01-08
EP0236619A1 (de) 1987-09-16
GB8525974D0 (en) 1985-11-27
NO864203L (no) 1987-04-23
NO864203D0 (no) 1986-10-21
NO174326B (no) 1994-01-10
JP2727074B2 (ja) 1998-03-11
JPS62187498A (ja) 1987-08-15
ES2040210T3 (es) 1993-10-16

Similar Documents

Publication Publication Date Title
NO174326C (no) Anvendelse av målsökende merket polypeptid
ES8602121A1 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
ATE106898T1 (de) Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
ATE66469T1 (de) Metall-radionuklid markiertes protein fuer diagnose und therapie.
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
ES290656Y (es) Dispositivo para recoger y mantener vivos los cultivos del cuerpo del paciente.
KR880009035A (ko) Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도
DE69730038D1 (de) Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen
DE3650322D1 (de) Fusionsproteine aus Interleukin-2 und Hirudin.
DE3876400T2 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ATE277628T1 (de) Behandlung von hematopoietischen zellen mit cxcr4 agonisten
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
EP0336779A3 (de) Durch kovalenten Ersatz von Wasserstoffbrücken stabilisierte Polypeptide
FR2759701B1 (fr) Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
ES544664A0 (es) Procedimiento para el diagnostico in vitro del sexo
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
DK1012285T3 (da) Hidtil ukendte beta-defensiner
IT1203782B (it) Impiego in terapeutica degli agonisti dopaminergici
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
DE69027542D1 (de) Solubilisierung und reinigung des rezeptors für das gastrin-freisetzende peptid
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
ES550932A0 (es) Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003